Implementation Science for the US President's Emergency Plan for AIDS Relief (PEPFAR)

Working with implementing organizations and governments in over 32 countries, the US President’s Emergency Plan for AIDS Relief (PEPFAR) has contributed to the rapid acceleration of HIV treatment access, availability of care and support services, and HIV prevention interventions. In the first phase of PEPFAR, these activities were appropriately carried out in an emergency fashion with the goal of using available interventions to reduce mortality and alleviate suffering from HIV disease as quickly and effectively as possible. Many lessons have been learned through examination of programs, including simple evaluations and operations research. Commensurate with the emergency response, however, state-of-the-art monitoring, evaluation, and research methodologies were not fully integrated or systematically performed. In the second phase of PEPFAR, characterized by an increased emphasis on sustainability, programs must demonstrate value and impact to be prioritized within complex and resource-constrained environments. In this context, there is a greater demand to causally attribute outcomes to programs. Better attribution can be used to inform midcourse corrections in the scale-up of new interventions (eg, male circumcision) or to reevaluate investments in programs for which impact is less clear. To meet these demands, PEPFAR is adopting an implementation science (IS) framework to improve the development and effectiveness of its programs at all levels. IS is the study of methods to improve the uptake, implementation, and translation of research findings into routine and common practices (the ‘‘know-do’’ or ‘‘evidence to program’’ gap). For example, IS was used to evaluate the routine operational effectiveness of the South African National Prevention of Mother-to-Child Transmission Programme. Investigators explored the survival of HIV-free infants across program sites and identified specific sources of variation such as health system factors (eg, limited antenatal visits and lack of syphilis screening) and individual behaviors (eg, breastfeeding practices). By framing the problem through IS, the study revealed opportunities for improving program performance that could be translated into immediate solutions (eg, improving quality of care, infant feeding counseling). In this way, IS proved to be a valuable tool that was used not only to improve program effectiveness, but also to explain what worked, why, and under what circumstances. Although no less rigorous than biomedical research dictated by a static protocol with robust internal validity (ie, ‘‘proof-of-concept’’ research with a precisely defined and narrow objective), an IS approach represents a paradigmatic shift in emphasis to greater external validity. The IS scope is also broader, seeking to improve program effectiveness and optimize efficiency, including the effective transfer of interventions from one setting to another. The methods of IS facilitate making evidence-based choices between competing or combined interventions and improving the delivery of effective and costeffective programs.

[1]  Laith J. Abu-Raddad,et al.  Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa , 2008, PLoS ONE.

[2]  G. Teruel,et al.  Randomization and Social Program Evaluation: The Case of Progresa , 2005 .

[3]  M L Brandeau,et al.  Optimal Investment in a Portfolio of HIV Prevention Programs , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  B. Chi,et al.  Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. , 2008, Bulletin of the World Health Organization.

[5]  William Rodriguez,et al.  Research for change: using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings. , 2007, The Journal of infectious diseases.

[6]  J. Baker Evaluating the Impact of Development Projects on Poverty: A Handbook for Practitioners , 2000 .

[7]  R. Chaisson,et al.  Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. , 2005, JAMA.

[8]  Jeffrey S. A. Stringer,et al.  Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A cluster randomized crossover trial to evaluate combined access to Nevirapine in developing countries , 2003 .

[9]  Megan E O'Brien,et al.  Can modeling of HIV treatment processes improve outcomes? Capitalizing on an operations research approach to the global pandemic , 2008, BMC health services research.

[10]  A. Nadim [Special program for research and training in tropical diseases]. , 1978, Annales de la Societe belge de medecine tropicale.

[11]  P. Nieburg,et al.  Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV , 2003, AIDS.

[12]  Jim Todd,et al.  Estimating Incidence from Prevalence in Generalised HIV Epidemics: Methods and Validation , 2008, PLoS medicine.

[13]  Nikhil Dutta,et al.  Global Fund To Fight AIDS, Tuberculosis, And Malaria , 2010 .

[14]  R. Lilford,et al.  Bmc Medical Research Methodology Open Access the Stepped Wedge Trial Design: a Systematic Review , 2022 .

[15]  Mark Chang,et al.  Adaptive Design Methods in Clinical Trials , 2006 .

[16]  Captain Y. B. Nusfield Public Health , 1906, Canadian Medical Association journal.

[17]  M. Colvin,et al.  Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1 , 2007, AIDS.

[18]  B. Chi,et al.  Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. , 2010, JAMA.

[19]  E. Duflo,et al.  Use of Randomization in the Evaluation of Development Effectiveness , 2004 .

[20]  M. E. Hoque,et al.  Effect of the Integrated Management of Childhood Illness strategy on childhood mortality and nutrition in a rural area in Bangladesh: a cluster randomised trial , 2009, The Lancet.

[21]  Jonathan P. Caulkins,et al.  Can Difficult-to-Reuse Syringes Reduce the Spread of HIV Among Injection Drug Users? , 1998, Interfaces.

[22]  K. Hofman,et al.  Implementation Science , 2007, Science.

[23]  Marcia Oliver,et al.  The US President's Emergency Plan for AIDS Relief , 2012 .

[24]  Peter M. A. Sloot,et al.  International Journal of Computer Mathematics Stochastic Simulation of Hiv Population Dynamics through Complex Network Modelling Stochastic Simulation of Hiv Population Dynamics through Complex Network Modelling , 2022 .

[25]  David P. Wilson,et al.  Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries , 2005, PLoS medicine.

[26]  C. Rayner,et al.  Randomized trial of an adherence programme for clients with HIV , 2003, International journal of STD & AIDS.

[27]  Esther Duflo,et al.  Scaling Up and Evaluation , 2003 .

[28]  J. Hughes,et al.  Design and analysis of stepped wedge cluster randomized trials. , 2007, Contemporary clinical trials.